Cargando…

Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic target

The pathogenesis and host-viral interactions of the Crimean–Congo hemorrhagic fever orthonairovirus (CCHFV) are convoluted and not well evaluated. Application of the multi-omics system biology approaches, including biological network analysis in elucidating the complex host-viral response, interroga...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neogi, Ujjwal, Elaldi, Nazif, Appelberg, Sofia, Ambikan, Anoop, Kennedy, Emma, Dowall, Stuart, Bagci, Binnur K, Gupta, Soham, Rodriguez, Jimmy E, Svensson-Akusjärvi, Sara, Monteil, Vanessa, Vegvari, Akos, Benfeitas, Rui, Banerjea, Akhil, Weber, Friedemann, Hewson, Roger, Mirazimi, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2022
Materias:	Immunology and Inflammation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018070/ https://www.ncbi.nlm.nih.gov/pubmed/35437144 http://dx.doi.org/10.7554/eLife.76071

Ejemplares similares

Systems-level temporal immune-metabolic profile in Crimean-Congo hemorrhagic fever virus infection
por: Ambikan, Anoop T., et al.
Publicado: (2023)

Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells
por: Appelberg, Sofia, et al.
Publicado: (2020)

Nucleoside-Modified mRNA Vaccines Protect IFNAR(–/–) Mice against Crimean-Congo Hemorrhagic Fever Virus Infection
por: Appelberg, Sofia, et al.
Publicado: (2022)

Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling
por: Akusjärvi, Sara Svensson, et al.
Publicado: (2021)

Genome-scale metabolic models for natural and long-term drug-induced viral control in HIV infection
por: Ambikan, Anoop T, et al.
Publicado: (2022)

Hazara virus and Crimean-Congo Hemorrhagic Fever Virus show a different pattern of entry in fully-polarized Caco-2 cell line
por: Monteil, Vanessa, et al.
Publicado: (2020)

Peripheral blood CD4(+)CCR6(+) compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals
por: Svensson Akusjärvi, Sara, et al.
Publicado: (2022)

Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus
por: Hawman, David W, et al.
Publicado: (2021)

Type-I interferon signatures in SARS-CoV-2 infected Huh7 cells
por: Chen, Xi, et al.
Publicado: (2021)

Development of vaccines against Crimean-Congo haemorrhagic fever virus
por: Dowall, Stuart D., et al.
Publicado: (2017)

Crimean-Congo Hemorrhagic Fever Virus in High-Risk Population, Turkey
por: Gunes, Turabi, et al.
Publicado: (2009)

Proteomic landscape of astrocytes and pericytes infected with HIV/SARS-CoV-2 mono/co-infection, impacting on neurological complications
por: Acharya, Arpan, et al.
Publicado: (2023)

Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zonoosis
por: Weber, Friedemann, et al.
Publicado: (2008)

Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 Replication
por: Krishnan, Shuba, et al.
Publicado: (2021)

A DNA-based vaccine protects against Crimean-Congo hemorrhagic fever virus disease in a Cynomolgus macaque model
por: Hawman, David W., et al.
Publicado: (2020)

Increased acquired protease inhibitor drug resistance mutations in minor HIV-1 quasispecies from infected patients suspected of failing on national second-line therapy in South Africa
por: Obasa, Adetayo Emmanuel, et al.
Publicado: (2021)

Treatment of Crimean-Congo Hemorrhagic Fever
por: Ergonul, Onder, et al.
Publicado: (2007)

Trans cohort metabolic reprogramming towards glutaminolysis in long-term successfully treated HIV-infection
por: Mikaeloff, Flora, et al.
Publicado: (2022)

Multi-omics personalized network analyses highlight progressive disruption of central metabolism associated with COVID-19 severity
por: Ambikan, Anoop T., et al.
Publicado: (2022)

Distinct lipid profile, low-level inflammation, and increased antioxidant defense signature in HIV-1 elite control status
por: Sperk, Maike, et al.
Publicado: (2021)

The DEVD motif of Crimean-Congo hemorrhagic fever virus nucleoprotein is essential for viral replication in tick cells
por: Salata, Cristiano, et al.
Publicado: (2018)

Presence of antibodies to Crimean Congo haemorrhagic fever virus in sheep in Tunisia, North Africa
por: Khamassi Khbou, Médiha, et al.
Publicado: (2021)

Sero-epidemiological survey of Crimean-Congo hemorrhagic fever virus in Tunisia
por: Wasfi, Fares, et al.
Publicado: (2016)

Role of myeloid cells in system-level immunometabolic dysregulation during prolonged successful HIV-1 treatment
por: Svensson Akusjärvi, Sara, et al.
Publicado: (2023)

1144 Healthcare Acquired Crimean Congo Hemorrhagic Fever in Turkey 2002-2012 - Low Risk of Transmission in Routine Diagnostic Laboratory Practice
por: Leblebicioglu, Hakan, et al.
Publicado: (2014)

Crimean-Congo Hemorrhagic Fever: Tick-Host-Virus Interactions
por: Papa, Anna, et al.
Publicado: (2017)

Enhanced Seroconversion to West Nile Virus Proteins in Mice by West Nile Kunjin Replicon Virus-like Particles Expressing Glycoproteins from Crimean–Congo Hemorrhagic Fever Virus
por: Tran, Pham-Tue-Hung, et al.
Publicado: (2022)

ISG15 overexpression compensates the defect of Crimean-Congo hemorrhagic fever virus polymerase bearing a protease-inactive ovarian tumor domain
por: Devignot, Stephanie, et al.
Publicado: (2020)

Crimean-Congo Hemorrhagic Fever Virus, Greece
por: Papa, Anna, et al.
Publicado: (2014)

Molecular Epidemiology, Genomics, and Phylogeny of Crimean-Congo Hemorrhagic Fever Virus
por: Hewson, Roger
Publicado: (2007)

Development of a novel recombinant ELISA for the detection of Crimean-Congo hemorrhagic fever virus IgG antibodies
por: Gülce-İz, Sultan, et al.
Publicado: (2021)

Biological Aging in People Living with HIV on Successful Antiretroviral Therapy: Do They Age Faster?
por: Akusjärvi, Sara Svensson, et al.
Publicado: (2023)

Cell-type-resolved quantitative proteomics map of interferon response against SARS-CoV-2
por: Saccon, Elisa, et al.
Publicado: (2021)

Comparison of Antiviral Activity of Recombinant and Natural Interferons Against Crimean-Congo Hemorrhagic Fever Virus
por: Karlberg, Helen, et al.
Publicado: (2010)

Absence of Crimean-Congo haemorrhagic fever virus in the tick Hyalomma aegyptium parasitizing the spur-thighed tortoise (Testudo graeca) in Tunisia
por: Fares, Wasfi, et al.
Publicado: (2019)

A Novel Vaccine against Crimean-Congo Haemorrhagic Fever Protects 100% of Animals against Lethal Challenge in a Mouse Model
por: Buttigieg, Karen R., et al.
Publicado: (2014)

Diagnostic Assays for Crimean-Congo Hemorrhagic Fever
por: Vanhomwegen, Jessica, et al.
Publicado: (2012)

A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease
por: Dowall, SD, et al.
Publicado: (2015)

Serological and Virological Evidence of Crimean-Congo Haemorrhagic Fever Virus Circulation in the Human Population of Borno State, Northeastern Nigeria
por: Bukbuk, David N., et al.
Publicado: (2016)

Adenoviral vectored vaccination protects against Crimean-Congo Haemorrhagic Fever disease in a lethal challenge model
por: Saunders, Jack E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0ip17q9tv1l3nn3vc1on75ulr3